No Data
No Data
CITIC Securities: the collagen industry's prosperity continues with significant growth among various leading companies, and there is ample potential for the future.
According to the Zhitong Finance APP, Citic Securities research report believes that the sales of restructured collagen products have been excellent, with brands such as Weweima, Kelifu, and Viyimi performing well this year.
Returns On Capital Signal Tricky Times Ahead For Guangdong Marubi Biotechnology (SHSE:603983)
If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see a company investing more capital into its business and ideally the returns earn
Subdued Growth No Barrier To Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) Price
When close to half the companies in China have price-to-earnings ratios (or "P/E's") below 31x, you may consider Guangdong Marubi Biotechnology Co., Ltd. (SHSE:603983) as a stock to potentially avoid
Marumi Co., Ltd. (603983.SH) 2023 equity distribution: $0.52 per share, share registration on May 30
Marumi Co., Ltd. (603983.SH) issued the 2023 equity distribution implementation notice. This time, profits are distributed to Israel...
Marumi Co., Ltd. (603983.SH): Not involved in hyaluronic acid-related medical and aesthetic projects
Gelonghui, May 23丨Marumi Co., Ltd. (603983.SH) said on an interactive platform that the company has not yet been involved in hyaluronic acid-related medical and aesthetic projects.
Marumi Co., Ltd. (603983.SH): Proposed additional investment in the “Smart Cosmetics Manufacturing Plant Construction Project”
Gelonghui, May 20 | Marumei Co., Ltd. (603983.SH) announced that the company plans to invest an additional 68.7526 million yuan in the “Smart Cosmetics Manufacturing Plant Construction Project” to add (expand) construction, add a warehousing and logistics center, support the construction of office and dormitory buildings, and add a new implementation site. The total investment amount of capital raised after the addition is RMB 344.46 million. The total investment amount of capital raised remains unchanged. The company will first complete the construction of civil construction and decoration projects. The shortfall will be covered by self-financing. The scheduled usage date of the “Cosmetics Intelligent Manufacturing Plant Construction Project” has been extended from December 2024
No Data